Home / Ingredient Directory / Vinpocetine

Reviewed by Yannis Lopez · Nutrition Industry Veteran

Last updated: August 6, 2026

Brain & Cerebral Blood Flow Periwinkle-Derived

Vinpocetine

Real cerebral blood flow research -- and a real safety warning worth knowing

Multiple human RCTs

2019 FDA pregnancy warning

Important: These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.

Real FDA safety warning, not a general caution: In June 2019, the FDA issued a specific safety communication advising pregnant women and women who could become pregnant not to take vinpocetine, based on animal reproductive studies (including an NIH National Toxicology Program report) showing decreased fetal weight and increased miscarriage risk. This is a documented, agency-issued warning -- not a vague "consult your doctor" boilerplate -- and it applies specifically to this ingredient.

Overview

Vinpocetine is a synthetic derivative of vincamine, a compound found in the lesser periwinkle plant (Vinca minor). It's been used as a prescription medication in parts of Europe and Asia for decades to treat cerebrovascular disorders, and is sold in the U.S. as a dietary supplement, most often marketed for memory and focus.

Its mechanism centers on improving cerebral blood flow and oxygen/glucose utilization in brain tissue, which is why most of its stronger human trial evidence comes from patients with an underlying blood flow problem — stroke recovery, chronic cerebral hypoperfusion — rather than healthy adults looking for a general cognitive edge. It's also one of the few supplement ingredients with a specific, documented FDA safety warning attached to it, which is worth understanding clearly before deciding whether it's right for you.

Potential Benefits

Cerebral Blood Flow

A large multicenter randomized trial in acute cerebral infarction patients found vinpocetine, added to standard treatment, improved cerebral blood flow along with cognitive and neurological function scores compared to standard treatment alone.

Cognitive Function (Hypoperfusion)

A 12-week oral therapy study in patients with chronic cerebral hypoperfusion found significant improvement in cognitive function on psychometric testing, alongside improved cerebrovascular reserve capacity.

Neuronal Energy Metabolism

Vinpocetine's proposed mechanism includes improving neuronal ATP production and glucose/oxygen utilization under conditions of reduced blood flow, distinct from stimulant-based "focus" ingredients.

Anti-Inflammatory Signaling

Preclinical research suggests vinpocetine may inhibit NF-κB inflammatory signaling, a pathway of interest in stroke and neuroinflammation research, though this is less established in human trials than its blood-flow effects.

Typical Dosage

Standard Daily Dose

10–30mg

Divided into 2-3 doses; most oral trials used doses in this range

What to Look For on the Label

A clear pregnancy warning statement

Reputable brands should carry the FDA-recommended warning on the label

Pro Tips

Not for pregnant women or women who could become pregnant, per the FDA's 2019 warning
Talk to your doctor before combining with blood thinners, since it has mild effects on platelet aggregation
Strongest evidence is in people with an underlying blood-flow issue, not as a general nootropic for healthy adults
Take with food to reduce mild stomach upset some users report

Research Snapshot

The multicenter CAVIN trial randomized 610 acute cerebral infarction patients to standard treatment with or without intravenous vinpocetine, finding significantly higher cognitive (MMSE), neurological (NIHSS), and functional (Barthel Index) scores in the vinpocetine group 90 days after treatment. Separately, a 12-week oral vinpocetine study in patients with chronic cerebral hypoperfusion found significant cognitive improvement on psychometric testing and improved cerebrovascular reserve capacity. Balancing this, the FDA's June 2019 safety communication -- based on animal data including an NIH National Toxicology Program report -- found vinpocetine associated with decreased fetal weight and increased miscarriage risk, leading to a formal warning against use in pregnant women and women who could become pregnant.

Source: Zhang et al., Clinical Drug Investigation (2016)

How Vinpocetine Compares

Ingredient	Best For	Key Difference
Vinpocetine	Cerebral Blood Flow, Post-Stroke Cognition	Real RCT data, but a documented FDA pregnancy warning
Ginkgo Biloba	Circulation, Memory	Similar blood-flow mechanism; no comparable FDA warning
Lion's Mane	Nerve Growth Factor, Focus	Different mechanism entirely; strong general safety profile
Citicoline	Focus, Neuronal Membrane Support	Works via phospholipid synthesis, not blood flow

These are the most common comparisons our customers ask about in-store.

Popular Stacks with Vinpocetine

Circulation & Focus

Vinpocetine + Ginkgo Biloba + Citicoline

Multi-pathway blood flow and cognitive support

Nootropic Foundation

Vinpocetine + Bacopa + L-Theanine

Common general nootropic combination

Healthy Aging Brain

Vinpocetine + Ergothioneine + Omega-3

Blood flow plus antioxidant cognitive support

Frequently Asked Questions

Is vinpocetine safe to take?

The FDA issued a formal safety warning in June 2019 advising pregnant women and women who could become pregnant not to take vinpocetine, based on animal data showing reduced fetal weight and increased miscarriage risk. Outside of pregnancy, most human trials report it as generally well tolerated, but anyone considering it should discuss it with their doctor first given this specific, documented concern.

Does vinpocetine actually improve memory or cognition?

There's real human trial evidence in specific populations. A 12-week oral therapy study in patients with chronic cerebral hypoperfusion found significant cognitive improvement on psychometric tests, and a large multicenter trial in acute cerebral infarction patients found improved cognitive and neurological scores. Evidence in healthy adults without an underlying blood flow issue is much thinner.

Why is vinpocetine legal if the FDA has concerns about it?

The FDA's 2019 action was a safety warning and labeling request, not a ban -- vinpocetine remains legally sold as a dietary supplement in the U.S. as of this writing, though the agency separately proposed in 2016 that it may not meet the legal definition of a dietary ingredient, a question that remains unresolved.

Sources & References

1. Zhang, W., Huang, Y., Li, Y., et al. (2016). Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clinical Drug Investigation, 36, 697–704.

2. Valikovics, A. (2007). Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions. Ideggyogyaszati Szemle, 60(7–8), 301–310.

3. U.S. Food and Drug Administration. (2019). Vinpocetine in Dietary Supplements. FDA Safety Communication.

All references are peer-reviewed studies or position stands from reputable organizations.